× Business BUSINESS MOTORING SHIPPING & LOGISTICS DR PESA FINANCIAL STANDARD Digital News Videos Health & Science Lifestyle Opinion Education Columnists Moi Cabinets Arts & Culture Fact Check Podcasts E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified Jobs Games Crosswords Sudoku The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS

UN to help boost Kenya’s pharmaceutical industry

By Xinhua | December 28th 2015

The United Nations Industrial Development Organisation (UNIDO) says it will help Kenya’s pharmaceutical industry reach international standards in order to reduce the cost of medicines.

Unido Consultant Wilberforce Wanyanga says the organisation plans to assist 34 pharmaceutical manufacturers meet World Health Organisation (WHO) pre-qualification standards in the next four years. “The aim is to make Kenyan medicines access the African continental market,” Mr Wanyanga said during the WTO side event on the role of patents in the pharmaceutical industry. So far, only one Kenyan manufacturing firm has met WHO standards.

In addition, the number of pharmaceutical firms that can produce malaria drugs has reduced from a high of 16 to two as the companies were not able to innovate drugs that could overcome the malaria parasite’s drug resistance. Wanyanga said that Unido will also offer technical assistance to Kenya’s pharmaceutical regulator in order to enhance its capability for surveillance on counterfeits. He added that Kenya is already East Africa’s regional hub for pharmaceutical industry.

Under Unido’s Good Manufacturing Practice (GMP), Kenya will become a low-cost producer of quality essential drugs for diseases such as HIV, tuberculosis and malaria. Wanyanga said that Kenya’s domestic manufacturers face hurdles in providing medicines for projects funded by international donors.

“This is because they need to attain highest quality standards and this has constrained the expansion of the industry,” he added. Domestic pharmaceutical production has numerous advantages. “Kenya will have access to freshly produced medicines that are closer to the market,” he added. Regulatory costs of controlling the quality of drugs will also be reduced significantly,” he added. Wanyanga said that reliance on imports leads to delays due to lengthy procedures required to clear medicines at border points.

Share this story
Kenyan farmers blame drop in flower production on heavy rains
“We hoped that the just-ended World Trade Organisation meeting would have addressed the issue of subsidies to ensure fair play but this was never to be,” Remeeus said.
Survey: Why 40 pc of workers want to quit their jobs
More than half of 18 to 25 year-olds in the workforce are considering quitting their job. And they are not the only ones.